These final results, together with a preceding report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 help the strategy of focusing on ACKR3 as a novel solution to modulate the opioid technique, which could open new therapeutic avenues for opioid-associated Problems. Increase healthier immune purpose: https://stratfordt714hfg6.onzeblog.com/profile